Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...

Around a fifth of users report not losing the expected amounts of weight on Mounjaro, and doctors have some answers ...

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.

GPs will be prescribing Mounjaro to a select few people as the rollout begins, but others may need to avoid the jabs completely ...

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...